Subscribe
  • Home
  • Issues
    • Online First
    • Latest Issue
    • Issue Archive
    • Special Issues
      • 2022 Midyear Review: Non–Small-Cell Lung Cancer
      • 2022 Oncology Biosimilar Guide to Patient Support Services
      • 2022 Breast Cancer Guide to Patient Support Services
  • Browse By Topic
    • Practice Management
    • Financial Management
    • Reimbursement
    • Health Policy
    • Quality Care
    • ICD Codes
    • Survivorship
    • FDA Approvals, News & Updates
    • In the News
  • Guide to Patient Support Services
    • Index
    • Introduction
    • 2023 Spotlight: Amgen
  • Conference Correspondent
    • ASCO 2022 - Wrap Up
    • NSCLC IO 2022 - Midyear Review
    • SABCS 2021 Wrap-Up
    • Dual IO 2021 Year in Review
  • Web Exclusives
    • Web Exclusive Articles
    • Videos
    • Interview with the Innovators
    • Webinars
    • Rapid Reactions
    • In the News
    • Quick Quiz
    • Multiple Myeloma Monthly Minutes
    • Melanoma Monthly Minutes
    • Press Releases
    • Women's Health Monthly Minutes
    • Lung Cancer Monthly Minutes
    • Gastrointestinal Cancer Monthly Minutes
  • Issues
  • 2014
  • June 2014, Vol 4, No 4

June 2014, Vol 4, No 4

Imbruvica (Ibrutinib) the First Bruton’s Tyrosine Kinase Inhibitor Approved for the Treatment of Patients with Relapsed Chronic Lymphocytic Leukemia
By Lisa A. Raedler, PhD, RPh
Drug Updates
Read More ›

Imbruvica YOU&i Access Program and Support for Patients
Read More ›

Providing Social Support to Patients with Cancer
Practice Management
Read More ›

ICD-9 or ICD-10: What Is the Point?
By Karna W. Morrow, CPC, RCC, CCS-P, PCS
Coding and Billing, Reimbursement
Regardless of which version you are considering, the International Classification of Diseases, Clinical Modification (ICD-CM) is a morbidity classification published by the United States for classifying diagnoses and reasons for visits in all healthcare settings. Read More ›

Shopping for High-Quality, Affordable Oncology Care
By Carla Balch, CEO
Quality Care
Read More ›

Drug Compounding: New Rule a Game Changer for Oncology Practices
By Dawn Holcombe, MBA, FACMPE, ACHE
From the Editor
Read More ›

Fair Labor Standards Act: Exemptions Review
By Robert D. Orzechowski, MBA, SPHR, SHRM-SCP
Read More ›

Do’s and Don’ts in Physician-Hospital Alignment, Part 1
By Max Reiboldt, CPA
Practice Management
Read More ›

FDA-Approved Medications Used for the Treatment of Lung Cancer
ICD Codes
Read More ›

New Clinical Trials Under Way
Clinical Trials Tracker
Read More ›

View the Latest Issue of OPM
View the Latest Issue
Read Issue

Top Trending Articles

1.
Molecular Characteristics Increasingly Define Adult Gliomas
By William King
2.
New NCCN Guidelines for CLL/SLL Include Second-Generation BTK Inhibitors
By William King
3.
Optimal Systemic Therapy for Renal Cell Carcinoma Is Still Evolving
By William King
  • Home
  • Issues
    • Online First
    • Latest Issue
    • Issue Archive
    • Special Issues
      • 2022 Midyear Review: Non–Small-Cell Lung Cancer
      • 2022 Oncology Biosimilar Guide to Patient Support Services
      • 2022 Breast Cancer Guide to Patient Support Services
  • Browse By Topic
    • Practice Management
    • Financial Management
    • Reimbursement
    • Health Policy
    • Quality Care
    • ICD Codes
    • Survivorship
    • FDA Approvals, News & Updates
    • In the News
  • Guide to Patient Support Services
    • Index
    • Introduction
    • 2023 Spotlight: Amgen
  • Conference Correspondent
    • ASCO 2022 - Wrap Up
    • NSCLC IO 2022 - Midyear Review
    • SABCS 2021 Wrap-Up
    • Dual IO 2021 Year in Review
  • Web Exclusives
    • Web Exclusive Articles
    • Videos
    • Interview with the Innovators
    • Webinars
    • Rapid Reactions
    • In the News
    • Quick Quiz
    • Multiple Myeloma Monthly Minutes
    • Melanoma Monthly Minutes
    • Press Releases
    • Women's Health Monthly Minutes
    • Lung Cancer Monthly Minutes
    • Gastrointestinal Cancer Monthly Minutes
CONNECT
Subscribe
  • About
    • About OPM
    • Editorial Board
    • Contact
  • Contribute
    • Submit a Manuscript
    • Author Guidelines
  • Connect
    • Join Us on LinkedIn
Sign Up for Oncology News

Subscribe to recieve the free, monthly OPM print publication and OPM weekly e‑newsletter.

Subscribe
© Amplity Health. All Rights Reserved. Privacy Policy.